This bill transfers all U.S. Agency for International Development (USAID) responsibilities related to the Food for Peace Act - including managing food aid programs, grants, permits, and regulations - to the U.S. Department of Agriculture (USDA). It directly affects USAID's Food for Peace operations and shifts program administration to the USDA Secretary, who will now handle all associated duties, assets, and legal authorities. The bill ensures continuity by requiring legal references to USAID to automatically apply to the USDA, and mandates the USDA to continue operating the Famine Early Warning Systems Network. Key provisions include immediate regulatory adjustments for program continuity and ongoing consultation with the State Department on food aid efforts.
S 526, the Pharmacy Benefit Manager Transparency Act of 2025, requires pharmacy benefit managers (PBMs) - the middlemen managing drug coverage for health plans - to disclose financial details and stop unfair practices. It prohibits PBMs from keeping price differences between what they charge health plans and pay pharmacies, arbitrarily clawing back payments, or inflating fees to offset government-mandated changes. PBMs must annually report to the FTC and HHS on rebate sharing, fee structures, formulary changes, and reimbursement differences, including whether drug tier shifts were influenced by manufacturers. This directly affects PBMs, pharmacies, health plans, and patients by increasing transparency in drug pricing and reimbursement.
Doctors in our Borders Act This bill increases the number of Conrad 30 waivers available each year from 30 to 100. Typically, a J-1 visa holder (nonimmigrant exchange visitor) must leave the United States for two years after finishing the exchange visitor program, including J-1 visa holders who entered the United States to receive graduate medical training. The Conrad 30 waiver program waives this requirement for eligible foreign medical graduates who agree to practice medicine in an underserved area or for an underserved population in the United States.
This bill creates a 10% tax credit for businesses that modernize or replace freight railcars, directly affecting railcar owners and manufacturers. To qualify, railcars must meet an 8% improvement standard in capacity or fuel efficiency, be built or modernized after enactment, and replace two scrapped railcars. The credit is limited to 1,000 qualified railcars per business annually, with reporting requirements for the Treasury to track claimed credits, scrapped railcars, and new railcar production. The credit applies to railcars placed in service after December 2024, ending three years after enactment.
HR 1189, the National Plan for Epilepsy Act, creates a coordinated federal strategy to address epilepsy through a National Plan for Epilepsy. The plan requires the Secretary of Health and Human Services to establish an annual assessment, maintain a diverse Advisory Council (including people with epilepsy, caregivers, and experts), and coordinate research and care across federal agencies. Key provisions include annual progress reports to Congress, data sharing between agencies, and recommendations to improve diagnosis, treatment access, and reduce epilepsy-related disparities. The plan expires December 31, 2035, and directly affects the estimated 3.4 million people in the U.S. living with epilepsy and their caregivers.
HR 1195, the Protect Medicaid Act, prohibits federal Medicaid funds from covering administrative costs related to health benefits provided to unauthorized immigrants who lack lawful immigration status and are ineligible for Medicaid. This directly affects states that currently provide such benefits, requiring them to separate these administrative costs from general Medicaid program expenses. The bill adds a new provision to the Social Security Act clarifying that federal funds cannot be used for these specific administrative costs, while allowing funds for systems designed to enforce this rule. It also mandates an Inspector General report detailing how states separate costs, ensure compliance, finance these programs (e.g., through provider taxes), and the impact on drug pricing for this population.
HR 1215, the Semiconductor Supply Chain Security and Diversification Act of 2025, aims to strengthen U.S. semiconductor security by promoting diversified supply chains across the Western Hemisphere. It directs the State Department, Commerce, and other agencies to support Western Hemisphere countries - particularly those with upper-middle or high-income economies - to develop their own semiconductor infrastructure, including mining critical minerals (like zinc and gallium) and testing facilities. The bill authorizes U.S. funding through the International Development Finance Corporation for these projects, requiring presidential certification that they advance U.S. interests and either benefit the poorest populations or counter strategic competitors. It focuses on building regional supply chain resilience through diplomatic support, regulatory cooperation, and market integration across the hemisphere.
The PREEMIE Reauthorization Act of 2025 extends federal research funding for preterm birth prevention and care through fiscal years 2025-2029, replacing the prior 2019-2023 period. It requires the HHS Secretary to establish an interagency working group within 18 months and mandates a National Academies study on preterm birth costs, risk factors, and prevention strategies. The study must assess neonatal intensive care costs, long-term family expenses, and opportunities for early detection and support. It also analyzes targeted research for at-risk pregnancies, state program best practices, and precision medicine approaches starting in pregnancy. This bill directly affects preterm infants, their families, and federal health agencies through these research and coordination mechanisms.
HR 1212 requires the Department of Homeland Security (DHS) to annually assess terrorism threats from terrorist groups using foreign messaging apps like Telegram, WeChat, and Weibo. The assessments must analyze how these apps facilitate radicalization, funding, and recruitment, while ensuring compliance with privacy and civil liberties laws. DHS must share findings with Congress and state/local fusion centers, and post unclassified reports publicly. This is a procedural bill focused on monitoring and reporting threats, not on banning apps or changing policies.
This bill creates new Small Business Administration (SBA) loan programs specifically for nonprofit child care centers that meet strict criteria, such as being tax-exempt 501(c)(3) organizations providing care for children from birth to school age. It makes these eligible centers qualify for standard SBA loans under sections 7(a) and 504, but requires loan guarantees for amounts over $500,000 and prohibits direct SBA lending (requiring partnerships with banks or financial institutions). The bill also mandates annual SBA reports to Congress tracking the number and value of these loans, while prohibiting loan denials based on religious associations and banning the use of funds for religious activities. This directly affects nonprofit child care centers seeking financing for facility improvements, staffing, or program expansion.
S.68, the Complete COVID Collections Act, extends the deadline for prosecuting fraud related to pandemic relief programs to 10 years and streamlines collection processes for small business loans. It requires the Small Business Administration to refer claims under $100,000 to the Treasury for collection, mandates monthly reports to Congress on collection efforts, and demands monthly DOJ reports detailing fraud prosecutions and recovered funds. The bill directly affects businesses that received CARES Act loans, restaurant grants, or venue operator funds, as well as the SBA, Treasury, and DOJ. Key provisions include standardizing fraud enforcement timelines across all covered programs and requiring public transparency on recovered funds through the Pandemic Response Accountability Committee.
Blind Americans Return to Work Act of 2025 This bill requires the Social Security Administration to carry out a demonstration project during which blind Social Security Disability Insurance (SSDI) beneficiaries receive reduced benefits commensurate with income above certain thresholds. Under current law, only individuals who earn under a specified monthly income, known as the substantial gainful activity (SGA) threshold, are considered disabled and thereby eligible for SSDI benefits. For blind workers, this limit is $2,700 per month in 2025. SSDI beneficiaries may earn beyond the SGA threshold for a limited period of time, known as the trial work period , before their benefits are suspended and ultimately terminate. The bill establishes a 20-year demonstration project during which individuals who are entitled to SSDI benefits by reason of blindness and who earn above the SGA threshold continue to receive benefits at an amount gradually reduced commensurate with their earnings beyond a specified amount. During this period, blind workers’ SSDI benefits must be reduced by $1 for every $2 that a worker earns above the sum of (1) the SGA threshold, and (2) the worker’s expenses reasonably attributable to their work. The SGA threshold may not be used to determine whether an individual is disabled during this period, and blind workers’ SSDI benefits may not be terminated due to work-related earnings. The trial work period also must not apply. After 10 years, affected beneficiaries may opt out of the modified benefits structure.
